Natus Medical reported $4.18M in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abiomed ABMD:US $ 65M 0.44M
Accuray ARAY:US $ -292000 4.27M
Atricure ATRC:US $ -14.15M 1.65M
Boston Scientific BSX:US $ 466M 286M
Cardiovascular Systems CSII:US $ -9.65M 1.09M
Cooper Companies COO:US $ 132.7M 1.9M
Cryolife CRY:US $ 1.16M 10.5M
Edwards Lifesciences EW:US $ 438.8M 64.4M
General Electric GE:US $ -716M 3747M
Globus Medical GMED:US $ 46.44M 28.24M
Inogen INGN:US $ -13586000 6.91M
Insulet PODD:US $ 37.9M 11M
Integra Lifesciences IART:US $ 47.46M 4.99M
Koninklijke Philips PHG:US -181000000 343M
Masimo MASI:US $ 59.74M 17.67M
Medtronic MDT:US $ 1670M 11M
Natus Medical BABY:US $ 4.18M 0.52M
Orthofix International OFIX:US $ -3.08M 6.28M
Perkinelmer PKI:US $ 254.84M 55.3M
Philips PHIA:NA € -181M 343M
Surmodics SRDX:US $ -4.9M 1.46M
Tandem Diabetes Care TNDM:US $ -15.34M 28.08M
Thermo Fisher Scientific TMO:US $ 2821M 1050M
Trinity Biotech TRIB:US $ -10.1M 10.68M